Table 2. Phenotype of spleen derived cells.
Untreated Balb/c Mice N = 5 | Islet-Tx N = 11 | NPC-Tx N = 6 | Co-NPC-Tx N = 10 | P | |
CD4+ | 31±2 | 24±3 | 27±6 | 15±8 a , b , c | <0.001 |
- CD25+ | 5±1 | 18±7 a | 10±6 | 26±8 a , c | <0.001 |
- FoxP3+ | 15+2 | 18±4 | 16±3 | 23±2 a , b , c | <0.001 |
- FoxP3+/CD25+ | 9+1 | 11±5 | 7±3 | 16±3 a , b , c | <0.001 |
- CD62L+ | 72±3 | 60±9 | Nt | 58±16 | Ns |
- CD25+/CD62L+ | 4±1 | 9±4 a | Nt | 10±2 a | 0.003 |
- CD45Rb high+ | 80±2 | 56±7 a | 57±5 a | 53±9 a | <0.001 |
CD8+ | 11±8 | 8±3 a | 6±2 a | 6±2 a | 0.001 |
- CD45Rb high+ | 93±1 | 75±6a | 71±6a | 63±20a | 0.002 |
CD14+ | 1±0.2 | 4±3 | 1±1 | 4±3 | Ns |
Gr1+ | 1±0.2 | 3±4 | 5±7 | 3±2 | Ns |
Gr1low/B220+ | 0.2±0.5 | 4±2 a , c | 2±1 | 4±2 a , c | <0.001 |
CD19+/B220+ | 41±3 | 53±7 | 42±2 | 50±20 | Ns |
- I-Ab+ | 1.5±0.3 | 12±7 a | 3±0.8 | 22±10 a , b , c | <0.001 |
- CD86+ | 0.5±0.5 | 21±14 a , c | 7±3 | 37±7 a , b , c | <0.001 |
CD11b+ | 1.5±0.1 | 4.2±2.3 | 7.8±2.9 | 4.8±2.1 a , b , c | <0.001 |
- I-Ab+ | 1.14±0.6 | 67±37 a | 33±25 | 89±8 a , c | <0.001 |
- CD80+ | 9±2 | 75±31 a | 54±31 a | 94±4 a , c | <0.001 |
- CD86+ | 9±2 | 73±32 a | 46±30 | 89±14 a , c | <0.001 |
Data are expressed as percentage ±SD. Statistical analysis was performed by one-way ANOVA with Bonferroni post-hoc test:
= p<0.05 vs Balb/c Mice;
= p<0.05 vs Islet-Tx;
= p<0.05 vs NPC-Tx; d = p<0.05 vs Co-NPC-Tx. Ns = not statistically significant; Nt = not tested.